Page last updated: 2024-11-02

pamidronate and Liver Cirrhosis

pamidronate has been researched along with Liver Cirrhosis in 1 studies

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spirlandeli, AL1
Dick-de-Paula, I1
Zamarioli, A1
Jorgetti, V1
Ramalho, LNZ1
Nogueira-Barbosa, MH1
Volpon, JB1
Jordão, AA1
Cunha, FQ1
Fukada, SY1
de Paula, FJA1

Other Studies

1 other study available for pamidronate and Liver Cirrhosis

ArticleYear
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
    Clinics (Sao Paulo, Brazil), 2017, Volume: 72, Issue:4

    Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling

2017